Tech Company Inital Public Offerings
Cabaletta Bio IPO
On 10/24/2019, Cabaletta Bio went public.
Transaction Overview
Company Name
Announced On
10/24/2019
Transaction Type
IPO
Amount
$74,800,000
Proceeds Purpose
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2929 Arch St. 600
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
Cabaletta Bio (Nasdaq: CABA) is a biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Nichtberger
Chief Financial Officer
Anup Marda
Chief Marketing Officer
David Chang
Chief Technical Officer
Gwendolyn Binder
VP - Bus. Development
Arun Das
Browse more venture capital transactions:
Prev: 10/24/2019: Truebill venture capital transaction
Next: 10/24/2019: Bizly venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs